checkpoint inhibitors market
Oct 14, 2022
Checkpoint Inhibitors: A Potential Approach in the Fight Against Refractory Cancer
Immune checkpoint inhibitors are drugs that inhibit immune checkpoints. These drugs allow immune cells to respond more strongly to cancer by blocking them. This blocks the “off” signal, allowing T-cells to kill cancer cells. Checkpoint inhibitors can be used to treat a variety of cancers, including lung cancer (...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
